← Back
NeuroTrials.ai
Neurology Clinical Trial Database

BP THROMBECTOMY METANALYSIS

Intensive Versus Standard Blood Pressure Control After Endovascular Thrombectomy in Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials

Year of Publication: 2026

Authors: Tallal M. Hashmi, Mushood Ahmed, Hadiah Ashraf, ..., Ameer E. Hassan

Journal: Journal of the American Heart Association

Citation: Hashmi TM, et al. Intensive Versus Standard Blood Pressure Control After Endovascular Thrombectomy in Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2026;15:e045503.

Link: https://doi.org/10.1161/JAHA.125.045503


Clinical Question

Does intensive systolic blood pressure reduction below 130–140 mmHg after successful mechanical thrombectomy improve functional outcomes compared to standard blood pressure management in acute ischemic stroke?

Bottom Line

Intensive post-thrombectomy blood pressure lowering (targeting SBP <130–140 mmHg) does not improve and may worsen outcomes, with significantly reduced good functional recovery, higher all-cause mortality, and markedly increased hypotensive episodes compared to standard management; clinicians should avoid aggressive BP reduction after successful recanalization.

Major Points

  • Meta-analysis of 6 RCTs encompassing 1902 patients demonstrates intensive BP control (SBP <130–140 mmHg) after thrombectomy does not improve functional outcomes
  • Intensive BP control significantly reduced the likelihood of good functional outcome (mRS 0–2 at 90 days): OR 0.70 (95% CI, 0.54–0.91) — a 30% relative reduction in odds
  • All-cause mortality at 90 days was significantly higher with intensive BP control: OR 1.21 (95% CI, 1.05–1.40)
  • Hypotensive episodes were more than twice as common with intensive BP control: OR 2.49 (95% CI, 1.56–3.96)
  • No significant difference in excellent functional outcome (mRS 0–1 at 90 days): OR 0.91 (95% CI, 0.67–1.23), P=0.44, I²=23%
  • No significant difference in symptomatic intracranial hemorrhage: OR 1.19 (95% CI, 0.89–1.61)
  • Evidence certainty was high for functional outcomes and hypotensive episodes; moderate for all-cause mortality and symptomatic intracranial hemorrhage
  • Current AHA/ASA guidelines recommending SBP ≤180/105 mmHg for ≥24 hours after recanalization are supported by this evidence
  • Postthrombectomy BP management should be approached cautiously — aggressive SBP reduction carries measurable harm without functional benefit

Design

Study Type: Systematic review and meta-analysis of randomized controlled trials

Randomization: 1

Blinding: Varied across included trials

Allocation: Varied across included trials

Enrollment Period: Inception to June 25, 2025 (search date)

Follow-up Duration: 90 days

Centers: 0

Countries: France, China, United States, South Korea, Canada

Sample Size: 1902

Analyzed: 1902

Analysis: Random-effects model; pooled odds ratios with 95% CIs; Hartung-Knapp-Sidik-Jonkman adjustment for CI accuracy; restricted maximum likelihood for between-study variance (τ²); leave-one-out sensitivity analysis; I² for heterogeneity; 95% prediction intervals; GRADE for certainty of evidence

Registration: PROSPERO CRD420251082965


Inclusion Criteria

  • Study design: randomized controlled trials only
  • Population: patients diagnosed with acute ischemic stroke resulting from large vessel occlusion
  • Intervention: intensive blood pressure control post-mechanical thrombectomy
  • Comparator: standard blood pressure control post-mechanical thrombectomy
  • Outcome: reporting at least one relevant outcome of interest

Exclusion Criteria

  • Non-randomized studies (observational studies, post hoc analyses, experimental studies)

Arms

FieldIntensive BP ControlControl
N944958
InterventionIntensive blood pressure lowering targeting SBP <130–140 mmHg (some trials targeting as low as 130 mmHg) following successful mechanical thrombectomyStandard blood pressure management per AHA/ASA guidelines (SBP ≤180/105 mmHg for at least 24 hours following recanalization)
DurationAt least 24 hours post-recanalization (varied across trials)At least 24 hours post-recanalization (varied across trials)

Outcomes

OutcomeTypeControlInterventionHR / OR / RRP-value
Excellent functional outcome (mRS 0–1 at 90 days) and good functional outcome (mRS 0–2 at 90 days)PrimaryReference (standard BP control)Intensive BP control0.7P=0.44 for excellent functional outcome (mRS 0–1); significant for good functional outcome (mRS 0–2)
Secondary
Secondary
Secondary
Safety
Safety

Subgroup Analysis

Leave-one-out sensitivity analysis conducted, sequentially excluding each of the 6 RCTs to evaluate effect on overall results; exclusion of BP-TARGET trial noted to affect excellent functional outcome sensitivity analysis


Criticisms

  • Only 6 RCTs included — insufficient number for funnel plot analysis or formal publication bias assessment
  • Heterogeneity in BP targets across trials (SBP <130 vs <140 mmHg) may limit interpretability of pooled estimates
  • Blinding varied across included trials, introducing potential performance and detection bias
  • Baseline characteristics differed across trials conducted in different countries and healthcare systems
  • The text is truncated; full sensitivity analysis results and all subgroup data not available in the provided source

Based on: BP THROMBECTOMY METANALYSIS (Journal of the American Heart Association, 2026)

Authors: Tallal M. Hashmi, Mushood Ahmed, Hadiah Ashraf, ..., Ameer E. Hassan

Citation: Hashmi TM, et al. Intensive Versus Standard Blood Pressure Control After Endovascular Thrombectomy in Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2026;15:e045503.

Content summarized and formatted by NeuroTrials.ai.